COVID-19 vaccines show promising results, but challenges ahead

This month, companies Pfizer and Moderna announced promising results for their COVID-19 vaccines, with early data showing both to be highly effective in preventing infection.

The speed of development and level of efficacy of the two vaccines is “remarkable,” said Margaret Hamburg, MD, former commissioner at the U.S. Food and Drug Administration, during the latest installment of the COVID-19 Conversations webinar series, “Vaccine Update: Development, Approval, Allocation and Distribution in the U.S.

If proven safe, the vaccines could be authorized for broader use by year’s end, with tens of millions of doses ready to distribute to front-line workers, as well as others by the spring. The news offers some hope, as the U.S. experiences a record surge in COVID-19 cases and deaths.

Click here to read the full article from APHA’s Public Health Newswire